|
IQVIA™ Real-World Insights Bibliography
| Real-world treatment of patients diagnosed with serious infections due to carbapenem-resistant Gram-negative pathogens in Greek hospitals |
| Author(s): Georgopoulos D1, Safarika A2, Ischaki E3, Filiou E4, Mantzarlis K5, Athanasopoulos D6, Fenoll R7, Sánchez E7, McCann E8 |
| Affiliations(s): 1 University Hospital of Crete, Crete, Greece 2 National and Kapodistrian University of Athens, Athens, Greece 3 General Hospital of Athens Evaggelismos, Athens, Greece 4 National and Kapodistrian University of Athens, Medical School, General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 5 University Hospital of Larissa, Larissa, Greece 6 Merck Sharp & Dohme Corp., Athens, Greece 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US |
Publication(s): ECCMID, Paris, France, 18-21 April 2020
|
| Document Type(s): Oral presentation, |
| Countries: Greece, |
C:
Y: |
Infectious disease,
2020 |
|
L:
A: |
English
Observational study, Retrospective Field Study, |
|
 |
| |
| |
| Resource utilisation associated with infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals |
| Author(s): Durante Mangoni E1, Georgopoulos D2, Fernández-Martínez M3, Mastroianni C4, Viale P5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Perivoliotis E11 ,Bou Arevalo G12, Koutsoukou A13, Mantzarlis K14, Lozano V15, Gómez-Ulloa D16, Roset M16, McCann E17 |
| Affiliations(s): 1 ‘L. Vanvitelli’ University, Monaldi Hospital, Naples, Italy 2 University Hospital of Crete, Crete, Greece 3 Marqués de Valdecilla University Hospital, Santander, Spain 4 Policlinico Umberto I, Rome, Italy 5 Policlinico S. Orsola-Malpighi, Bologna, Italy 6 University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US |
Publication(s): ECCMID, Paris, France, 18-21 April 2020
|
| Document Type(s): Oral presentation, |
| Countries: Greece, Italy, Spain, |
C:
Y: |
Infectious disease,
2020 |
|
L:
A: |
English
Observational study, Retrospective Field Study, |
|
|
| |
| |
| Outcomes and predictors of outcomes of serious infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals |
| Author(s): Georgopoulos D1, Durante Mangoni E2, Mastroianni C3, Viale P4, Arnáiz de las Revillas F5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Malachias S11, Bou Arevalo G12, Kyriakoudi A13, Tsolaki V14, Lopez D15, Gómez-Ulloa D16, Lara N16, McCann E17 |
| Affiliations(s): 1 University Hospital of Crete, Crete, Greece 2 ‘L. Vanvitelli’, Monaldi Hospital, Naples, Italy 3 Policlinico Umberto I, Rome, Italy 4 Policlinico S. Orsola-Malpighi, Bologna, Italy 5 Marqués de Valdecilla University Hospital, Santander, Spain 6University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’, Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US |
Publication(s): ECCMID, Paris, France, 18-21 April 2020
|
| Document Type(s): Oral presentation, |
| Countries: Greece, Italy, Spain, |
C:
Y: |
Infectious disease,
2020 |
|
L:
A: |
English
Observational study, Retrospective Field Study, |
|
|
| |
| |
| EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE |
| Author(s): Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi |
| Affiliations(s): Real World Evidence Solutions, IQVIA, France;
Global Pharmacovigilance – Global Safety Sciences - Risk Management, Sanofi;
Epidemiology and Benefit Risk Evaluation, Sanofi;
Global Clinical Sciences;
Vaccines & Anti-Infectives, Mylan, The Netherlands |
Publication(s): Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019
|
| Document Type(s): Poster, |
| Countries: France, Greece, Italy, Portugal, |
| Click here for the abstract |
C:
Y: |
Health policy, Musculoskeletal disease,
2019 |
|
L:
A: |
English
Survey research, |
|
|
| |
| |
| Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use |
| Author(s): Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M |
| Affiliations(s): IQVIA |
Publication(s): Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
|
| Document Type(s): Article, |
| Countries: France, Greece, Italy, Portugal, |
| Click here for the abstract |
C:
Y: |
Musculoskeletal disease, Rheumatology, Risk Management & REMS,
2019 |
|
L:
A: |
English
Survey research, |
|
|
| |
| |
| Patient and caregiver indirect costs after acute cardiovascular events in Europe. |
| Author(s): Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5 |
| Affiliations(s): 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium |
Publication(s): ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
|
| Document Type(s): Oral presentation, |
| Countries: Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Health economics,
2018 |
|
L:
A: |
English
Burden of illness, Cost of illness, |
|
|
| |
| |
| Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model |
| Author(s): Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 |
| Affiliations(s): 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany |
Publication(s): JHEOR 2017;5(1):89-108
|
| Document Type(s): Article, |
| Countries: Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK, |
C:
Y: |
Immunology and Vaccination, Infectious disease, Respiratory disease,
2017 |
|
L:
A: |
English
Epidemiological study, Public Health, |
|
|
| |
| |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
Publication(s): Clinical Epidemiology
|
| Document Type(s): Article, |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK, |
| Click here for the abstract |
C:
Y: |
Oncology,
2016 |
|
L:
A: |
English
Literature Review, |
|
|
| |
| |
| Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study. |
| Author(s): Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. |
| Affiliations(s): 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com.
2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium.
3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany.
4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom.
6Gastroenterology Practice, Minden, Germany.
7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece.
8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom.
10IMS Health, Real World Evidence Solutions, Spain.
11Merck & Co., Inc., Kenilworth, NJ, United States
|
Publication(s):
Dig Liver Dis. 2016 Jun;48(6):601-7.
|
| Document Type(s): Article, |
| Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK, |
C:
Y: |
Gastrointestinal disorders,
2016 |
|
L:
A: |
English
Burden of illness, Patient questionnaire, Survey research, |
|
|
| |
| |
| Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study |
| Author(s): Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. |
| Affiliations(s): 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be.
2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.
3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany.
4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK.
6Gastroenterology Practice, Minden, Germany.
7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece.
8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK.
10IMS Health, Real World Evidence Solutions, Barcelona, Spain.
11Merck & Co., Inc., Rahway, NJ, United States.
|
Publication(s): Dig Liver Dis. 2016 Jun;48(6):592-600
|
| Document Type(s): Article, |
| Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK, |
C:
Y: |
Gastrointestinal disorders,
2016 |
|
L:
A: |
English
Burden of illness, Patient questionnaire, |
|
|
| |
| |
 1 of 3 
|
|
